...
首页> 外文期刊>Cogent Medicine >Preference for shared decision-making in Japanese patients with rheumatoid arthritis
【24h】

Preference for shared decision-making in Japanese patients with rheumatoid arthritis

机译:首选日本类风湿关节炎患者的共同决策

获取原文
           

摘要

Purpose : The goal of this study was to examine preference for collaborative decision-making in Japanese patients with rheumatoid arthritis (RA). Patients and methods : A national online survey identified five hundred Japanese patients with RA who met study eligibility criteria. Subjects were queried regarding their preference for shared decision-making (SDM), using a questionnaire developed by Baars et al. to evaluate preference for SDM among Dutch patients. Participants in this study were asked to identify a number of clinical and socioeconomic characteristics, medical history, and treatment details. Multivariable regression analyses were applied to determine factors that were related to patient preference for SDM. Results : The study showed that 52% of patients surveyed considered shared medical decision-making “Very important” on a 4-item Likert scale. Females and patients with RA in Japan who are treated with biologic agents are more likely to have a preference for SDM. On the other hand, patients with a comorbidity of depression are less likely to prefer SDM. Conclusion : A majority of Japanese patients with RA prefer a collaborative role in medical decision-making. Treatment with biologic agents is associated with a higher likelihood of preference for SDM.
机译:目的:本研究的目的是检验日本类风湿关节炎(RA)患者对协作决策的偏好。患者和方法:一项全国在线调查确定了五百名符合研究入选标准的日本RA患者。使用由Baars等人开发的问卷调查表,询问受试者是否偏爱共享决策(SDM)。评估荷兰患者对SDM的偏爱。要求这项研究的参与者确定许多临床和社会经济特征,病史和治疗细节。应用多变量回归分析来确定与患者对SDM偏爱相关的因素。结果:该研究表明,接受调查的患者中有52%在4项李克特量表上认为共同的医疗决策“非常重要”。在日本,接受过生物制剂治疗的女性和RA患者更倾向于SDM。另一方面,患有抑郁症的合并症患者不太可能喜欢SDM。结论:大多数日本RA患者更喜欢在医疗决策中发挥协同作用。用生物制剂治疗与更倾向于SDM相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号